Pharmaceutical Market Europe • May 2022 • 3

COMMENT

Behaviour change –
a maze of decisions

In our cover article this month, Danny Buckland looks at behaviour change, and how the pandemic, with its sudden sharp focus on the correlation between behaviour and health outcomes, delivered a huge jolt to society, encouraging people to realise that behaviour is as important to health as the most innovative science.

As Danny explains, fresh thinking and commitment to clearer understandings of the nuances that are at the heart of behaviour are starting to unlock the gains that could transform healthcare systems that are under huge pressure. Read more on page 32.

Also in this month’s issue, we have an article from Paul Chew, Chief Medical Officer at Phesi, who talks about the importance of building a resilient clinical development strategy – especially now, when local events are having a global impact. Read more on page 16.

Once again, we have our annual communications excellence special feature in the May issue of PME. This time we have 18 agencies contributing to this feature, so for a closer look, turn to page 22.

Looking ahead, our June issue will look at tackling key health challenges through innovation and creativity in healthcare. Creativity leads to innovation, and innovation in healthcare is vital to deal with the ever-growing demands of a healthcare system that is faced with an ageing population, an increase in chronic disease and illnesses, and wider requirements for more personalised patient care. In next month’s issue we’ll look at the influence of creativity in healthcare and the role novel thinking can play in improving established routines.

If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com

I hope you enjoy this issue!

Image

Iona Everson
Group Managing Editor

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Journalist/editorial assistant
Fleur Jeffries

Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2022 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image